To The Moon

When technology stocks sell off, investors often look for businesses with dependable earnings, strong balance sheets and reliable cash flow. Recent market movements suggest that rotation is happening again.

During the latest tech pullback, Procter & Gamble ($PG) gained 5.58%, Coca-Cola ($KO) rose 2.87%, Eli Lilly ($LLY) climbed 2.83%, Walmart ($WMT) advanced 2.82%, Costco ($COST) added 1.99%, and Berkshire Hathaway ($BRK.B) gained 1.32%, according to the supplied market figures.

The appeal is straightforward: when uncertainty rises around AI valuations and future earnings, businesses selling everyday products and essential services can look more attractive.

But there is another side to this trade. Defensive stocks can become expensive when too many investors rush to safety at the same time.

💰 Berkshire Is More Than a Safe Haven

Berkshire Hathaway has become a prominent beneficiary of the shift towards established businesses and strong balance sheets.

Its cash and Treasury holdings stood at approximately $364.7 billion at the end of June 2026. However, the company has also started putting some of that capital to work.

In the second quarter, Berkshire repurchased $4.5 billion of its own shares and bought more stocks than it sold for the first time in 14 quarters. Its purchases included a substantial increase in Alphabet ($GOOGL), while it also acquired homebuilder Taylor Morrison.

These moves suggest Berkshire is not simply waiting for markets to fall. Under CEO Greg Abel, it has begun deploying capital while retaining a substantial financial cushion. Warren Buffett remains chairman. 

🛒 Why Defensive Stocks Are Attracting Attention

Consumer staples: PG and KO sell everyday products, providing relatively dependable demand even when consumers become more cautious.

Retail: Walmart and Costco benefit from their scale, competitive pricing and established customer bases. However, their shares can still be vulnerable if valuations become excessive.

Healthcare: Eli Lilly offers exposure to pharmaceutical innovation and demand for treatments, although drug development, competition and pricing pressures remain important risks.

Berkshire Hathaway: Its diversified businesses, insurance operations and large cash reserves provide a different kind of exposure from a concentrated technology portfolio.

These companies are not interchangeable, and none is immune to a market downturn. Their earnings resilience and valuations still need to be assessed individually.

⚠️ The Hidden Risk: Paying Too Much for Safety

A defensive business can be fundamentally strong but still deliver disappointing investment returns if purchased at an excessive valuation.

When investors crowd into consumer staples and established companies, share prices can rise faster than earnings. If technology stocks recover, some money may rotate back into growth stocks, leaving defensive shares vulnerable to a pullback.

There is also a broader economic risk. Higher interest rates and persistent inflation can raise costs, pressure consumers and reduce the appeal of dividend-paying stocks.

The recent rally therefore raises an important distinction: are investors buying these businesses because their long-term earnings prospects have improved, or simply because technology stocks have become less attractive in the short term?

🔍 What Would Confirm a Lasting Rotation?

Three developments would make the shift more convincing:

• Earnings resilience: Defensive companies continue delivering solid results rather than benefiting only from temporary market sentiment.

• Sustained market leadership: Defensive stocks outperform over several weeks or months, not just during a brief sell-off.

• More reasonable valuations: Investors continue buying these businesses without pushing their prices too far ahead of underlying earnings.

If technology earnings disappoint while defensive companies maintain steady growth, the rotation could last longer. If AI spending concerns ease and tech earnings remain strong, the recent shift may prove temporary.

📌 The Bottom Line

The return of the Buffett trade reflects a familiar market lesson: when uncertainty rises, cash flow and financial strength become more valuable.

Berkshire’s capital deployment adds another dimension to the story. It is maintaining a huge cash reserve while selectively investing in businesses and buying back its own shares.

But following the money into defensive stocks is not automatically a winning strategy. The price paid still matters.

The real test is whether defensive stocks can continue delivering attractive returns after their recent rally—or whether investors have already paid a premium for protection.

For discussion purposes only.